Effects of Marital Status on Prognosis in Women with Infiltrating Ductal Carcinoma of the Breast: A Real-World 1: 1 Propensity-Matched Study

Lan, Tian; Lu, Yunyan; Luo, Hua; He, Jinlan; He, Jiawei; Hu, Zujian; Xu, Huiling

doi:10.12659/msm.923630

Cited by 8 publications

(5 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The study found that duct carcinoma and infiltrating duct carcinoma were more prevalent in married patients than in widowed or divorced individuals. The results of this study are consistent with previous research that has shown a higher risk of breast cancer in unmarried individuals (Lan et al, 2020).…”

Section: Discussionsupporting

confidence: 93%

See 1 more Smart Citation

Pollutions and Incidence of Liver and Breast Cancer in Damietta Governorate, Egypt: A Multiregional Analysis

Moawed,

Gohar,

El–tohamy

et al. 2024

Preprint

View full text Add to dashboard Cite

Cancer stands as a pervasive global health concern, ranking among the leading causes of morbidity and mortality worldwide. This paper addresses this challenge by presenting a focused analysis of liver and breast cancer incidence rates in Damietta Governorate, Egypt, utilizing statistical data from 2021.The study meticulously divided Damietta Governorate into distinct regions for comprehensive analysis. Medical records, comprising 128 cases for liver cancer and 100 cases for breast cancer, were diligently collected from Damietta Cancer Center's Oncology Institute and death records throughout 2021. Incidence rates for both cancers were meticulously analyzed, considering factors such as sex, age, occupation, location, stage, grade, and diagnosis. The results highlighted a significant increase in liver cancer incidence rates by 2021, signaling a growing burden in Damietta Governorate. Similarly, projections indicated an upward trend in breast cancer incidence rates, with distinct variations observed in types like duct carcinoma and infiltrating duct carcinoma across specific regions. Noteworthy differences were also observed in age groups, marital status, and occupation. This study contributes valuable insights into the escalating incidence of liver and breast cancer in Damietta Governorate, emphasizing the urgency of continued monitoring and intervention efforts. The specific nuances in breast cancer types and demographic variations underscore the necessity for targeted strategies to alleviate the escalating burden of these diseases in the region. Ongoing surveillance and effective interventions are paramount to combat the rising incidence of liver and breast cancer in Damietta Governorate. Our results suggest a potential correlation between environmental pollution and cancer incidence rates in Damietta Governorate. Given the region's industrial activities and environmental challenges, the link between pollution and cancer warrants further investigation. Understanding and addressing the impact of pollution on cancer rates is crucial for developing effective prevention and intervention strategies.

show abstract

Section: Discussionsupporting

confidence: 93%

“…Another study found that marital status can also affect the prognosis of women with infiltrating ductal carcinoma of the breast, with married patients having a higher 5-year overall survival rate than divorced, single, or widowed patients (Lan et al, 2020).…”

Section: Discussionmentioning

confidence: 99%

Pollutions and Incidence of Liver and Breast Cancer in Damietta Governorate, Egypt: A Multiregional Analysis

Moawed,

Gohar,

El–tohamy

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…Our multivariate analysis revealed that age ≥70 years, high grade, T2 stage, triple-negative subtype, and no adjuvant radiotherapy were poor prognostic factors for OS. Marital status was also a predictor of OS, single or divorced marital status predicted poor survival, which agrees with the study of Lan, who found that divorced or widowed marital status showed the highest mortality risk among BC patients with IDC (33).…”

Section: Discussionsupporting

confidence: 90%

Evaluation of adjuvant therapy for T1-2N1miM0 breast cancer without further axillary lymph node dissection

Baiyu

Li²,

Wu³

et al. 2023

Front. Surg.

View full text Add to dashboard Cite

BackgroundFor breast cancer (BC) with sentinel lymph node micrometastases (SLNMs), there are limited data to guide the selection of postoperative adjuvant therapy. This study aimed to identify target populations who might benefit most from adjuvant therapy and examine prognostic factors among patients with T1-2N1miM0 BC with one or two SLNMs who underwent sentinel lymph node biopsy (SLNB) alone.MethodsThere were 7,423 patients diagnosed with T1-2N1miM0 BC between 2010 and 2015, and patients with one or two SLNMs were extracted from the Surveillance, Epidemiology, and End Results database. All the patients underwent SLNB alone without further axillary lymph node dissection, and they were stratified according to adjuvant therapy. The statistical significance of categorical variables was analyzed using the χ2 test. Univariable and multivariable Cox analyses were used to analyze characteristics predictive of Breast-cancer-specific survival and overall survival (OS). Kaplan–Meier methods with the log-rank test was analyzed to compare survival difference between the different treatments.ResultsAdjuvant chemotherapy and radiotherapy improved 5-year OS rates. Multivariate analysis revealed that age ≥70 years, high grade, T2 stage, triple-negative subtype, and absence of radiotherapy were poor prognostic factors for OS. Patients who received breast-conserving surgery (BCS), and those with invasive ductal carcinoma (IDC), luminal A, luminal B, or basal-like subtype, and T1c or T2 stage benefited from adjuvant radiotherapy. Patients who received BCS, and those with IDC, luminal A subtype, and T1b, T1c, or T2 stage benefited from adjuvant chemotherapy.ConclusionOur findings provide a clinical evaluation of treatment choice after surgery, which may help clinicians make individualized clinical decisions.

show abstract

“…The incidence of BC has been increasing in recent years, and it is affecting women at a younger age, posing significant risks to their health and well-being[ 17 ]. Early-stage BIDC often goes undetected, leading to a diagnosis at advanced stages with tumor metastasis, contributing to the poor prognosis of BIDC[ 18 ]. Therefore, analyzing the expression profiles and clinical implications of FOXM1, COX-2, and GRP78 in BIDC is essential for advancing research in this field.…”

Section: Discussionmentioning

confidence: 99%

Clinical implications of forkhead box M1, cyclooxygenase-2, and glucose-regulated protein 78 in breast invasive ductal carcinoma

Bai,

Li,

Cai

2023

World J Clin Cases

View full text Add to dashboard Cite

Rehabilitation of lower limb amputation in developing countries is quite challenging. Though there are basic to highly advanced prostheses available in India, the set-up is still facing difficulties in developing countries. Prosthetic management is difficult due to lack of availability of prostheses and reduced affordability among low income populations. In this review we highlighted the lower limb amputation and prosthetic rehabilitation status in India. Currently, India is advancing well in the rehabilitation field, but further studies are required to provide more evidence and recommendation.

show abstract

Effects of Marital Status on Prognosis in Women with Infiltrating Ductal Carcinoma of the Breast: A Real-World 1: 1 Propensity-Matched Study

Cited by 8 publications

References 38 publications

Pollutions and Incidence of Liver and Breast Cancer in Damietta Governorate, Egypt: A Multiregional Analysis

Pollutions and Incidence of Liver and Breast Cancer in Damietta Governorate, Egypt: A Multiregional Analysis

Evaluation of adjuvant therapy for T1-2N1miM0 breast cancer without further axillary lymph node dissection

Clinical implications of forkhead box M1, cyclooxygenase-2, and glucose-regulated protein 78 in breast invasive ductal carcinoma

Contact Info

Product

Resources

About